Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 753 Views
-
Last post by NHE
-
- 0 Replies
- 2146 Views
-
Last post by frodo
-
- 0 Replies
- 1026 Views
-
Last post by NHE
-
- 0 Replies
- 1255 Views
-
Last post by frodo
-
- 1 Replies
- 966 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1217 Views
-
Last post by NHE
-
- 0 Replies
- 1973 Views
-
Last post by vesta
-
- 1 Replies
- 1054 Views
-
Last post by Petr75